Basic Information
LncRNA/CircRNA Name | LINC01296 |
Synonyms | DUXAP9, LINC01296, FLJ39632, lncRNA-CTD903 |
Region | GRCh38_14:19062316-19131167 |
Ensemble | ENSG00000225210 |
Refseq | NA |
Classification Information
Regulatory Mechanism | Biological Function | Clinical Application | |||
---|---|---|---|---|---|
TF | Immune | Survival | |||
Enhancer | Apoptosis | Drug | |||
Variant | Cell Growth | Circulating | |||
MiRNA | EMT | Metastasis | |||
Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
Cancer Name | non small cell lung cancer |
ICD-0-3 | C34 |
Methods | qPCR |
Sample | NSCLC tissues,cell line(A549) |
Expression Pattern | up-regulated |
Function Description | Overexpression of LINC01296 inhibited the expression of miR-5095 in the A549 cell. Furthermore, the miR-5095 expression was downregulated in the NSCLC tissues than in the adjacent non-tumor tissues. |
Pubmed ID | 30899389 |
Year | 2019 |
Title | Long noncoding RNA LINC01296 induces non-small cell lung cancer growth and progression through sponging miR-5095. |
External Links
Links for LINC01296 | GenBank HGNC NONCODE |
Links for non small cell lung cancer | OMIM COSMIC |